speb/financial-data huggingface dataset:
COUR income_statement (quarterly, 2025-03-31) — Pretax Income: -6300000.00
COUR cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 1200000.00
COUR balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
COUR cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -500000.00
COUR balance_sheet (quarterly, 2025-03-31) — Receivables: 59900000.00
COUR income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 81400000.00
COUR income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7100000.00
COUR cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
COUR income_statement (quarterly, 2025-03-31) — Research And Development: 29500000.00
COUR income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: -900000.00
COUR balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -868000000.00
COUR cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 0.00
COUR income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 56800000.00
COUR income_statement (quarterly, 2025-03-31) — Selling General And Administration: 83700000.00
COUR balance_sheet (quarterly, 2025-03-31) — Share Issued: 165300000.00
COUR income_statement (quarterly, 2025-03-31) — Special Income Charges: 900000.00
COUR cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 24200000.00
COUR balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 610500000.00
COUR balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 585600000.00
COUR income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 189000.00
COUR income_statement (quarterly, 2025-03-31) — Tax Provision: 1500000.00
COUR income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
COUR balance_sheet (quarterly, 2025-03-31) — Total Assets: 951200000.00
COUR balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 610500000.00
COUR balance_sheet (quarterly, 2025-03-31) — Total Debt: 3100000.00
COUR balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 610500000.00
COUR income_statement (quarterly, 2025-03-31) — Total Expenses: 194600000.00
COUR balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 340700000.00
COUR balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 97200000.00
COUR balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 6200000.00
COUR income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -14400000.00
COUR income_statement (quarterly, 2025-03-31) — Total Unusual Items: 900000.00
COUR income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 900000.00
COUR balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 4000000.00
COUR balance_sheet (quarterly, 2025-03-31) — Treasury Stock: 37800000.00
COUR balance_sheet (quarterly, 2025-03-31) — Working Capital: 519500000.00
COUR income_statement (quarterly, 2025-06-30) — +Operating Expense: 117800000.00
COUR income_statement (quarterly, 2025-06-30) — +Total Revenue: 187100000.00
COUR balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 58200000.00
COUR balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -73400000.00
COUR balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1519800000.00
COUR cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 2200000.00
COUR income_statement (quarterly, 2025-06-30) — Basic Average Shares: 162500000.00
COUR income_statement (quarterly, 2025-06-30) — Basic EPS: -0.05
COUR cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 748700000.00
COUR cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -5100000.00
COUR cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -4700000.00
COUR balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
COUR balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 775100000.00
COUR balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 775100000.00
COUR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -1500000.00
COUR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -6900000.00
COUR cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 35500000.00
COUR cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 7700000.00
COUR cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 3500000.00
COUR cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 900000.00
COUR cash_flow (quarterly, 2025-06-30) — Change In Payable: 7700000.00
COUR cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 11200000.00
COUR cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 5200000.00
COUR cash_flow (quarterly, 2025-06-30) — Change In Receivables: -7300000.00
COUR cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 10000000.00
COUR cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -7300000.00
COUR cash_flow (quarterly, 2025-06-30) — Changes In Cash: 27100000.00
COUR balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
COUR balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 627000000.00
COUR cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
COUR income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 84400000.00
COUR balance_sheet (quarterly, 2025-06-30) — Current Assets: 881900000.00
COUR balance_sheet (quarterly, 2025-06-30) — Current Deferred Assets: 20200000.00
COUR balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 186000000.00
COUR balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 186000000.00
COUR balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 346200000.00
COUR cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 7400000.00
COUR cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 7400000.00
COUR income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 162500000.00
COUR income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.05
COUR income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -7800000.00
COUR income_statement (quarterly, 2025-06-30) — EBIT: -15100000.00
COUR income_statement (quarterly, 2025-06-30) — EBITDA: -7700000.00
COUR cash_flow (quarterly, 2025-06-30) — End Cash Position: 775800000.00
COUR cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -1500000.00
COUR cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 30400000.00
COUR income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 24900000.00
COUR balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 26400000.00
COUR balance_sheet (quarterly, 2025-06-30) — Gross PPE: 113400000.00
COUR income_statement (quarterly, 2025-06-30) — Gross Profit: 102700000.00
COUR cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 1700000.00
COUR income_statement (quarterly, 2025-06-30) — Interest Income: 8000000.00
COUR income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 8000000.00
COUR balance_sheet (quarterly, 2025-06-30) — Invested Capital: 627000000.00
COUR cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -6900000.00
COUR balance_sheet (quarterly, 2025-06-30) — Leases: 1100000.00
COUR balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 112300000.00
COUR cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
COUR income_statement (quarterly, 2025-06-30) — Net Income: -7800000.00
COUR income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -7800000.00
COUR income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -7800000.00
COUR income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -7800000.00
COUR income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -7800000.00
COUR cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -7800000.00
COUR income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -7800000.00
COUR income_statement (quarterly, 2025-06-30) — Net Interest Income: 8000000.00
COUR cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
COUR income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 8000000.00
COUR cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -6900000.00
COUR cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -1800000.00
COUR balance_sheet (quarterly, 2025-06-30) — Net PPE: 40000000.00
COUR cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -400000.00
COUR balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 600600000.00
COUR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 1800000.00
COUR balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 1800000.00
COUR income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -7700000.00
COUR income_statement (quarterly, 2025-06-30) — Normalized Income: -7800000.00
COUR cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 35500000.00
COUR income_statement (quarterly, 2025-06-30) — Operating Income: -15100000.00
COUR income_statement (quarterly, 2025-06-30) — Operating Revenue: 187100000.00
COUR balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 163500000.00
COUR balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 19400000.00
COUR balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 115300000.00
COUR income_statement (quarterly, 2025-06-30) — Other Gand A: 24900000.00
COUR income_statement (quarterly, 2025-06-30) — Other Income Expense: 100000.00
COUR balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 26400000.00
COUR cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -400000.00
COUR balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 31600000.00
COUR balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 4900000.00
COUR income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 100000.00
COUR balance_sheet (quarterly, 2025-06-30) — Other Payable: 22700000.00
COUR balance_sheet (quarterly, 2025-06-30) — Other Receivables: 9000000.00
COUR balance_sheet (quarterly, 2025-06-30) — Payables: 22700000.00
COUR balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 22700000.00
COUR balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 22200000.00
COUR balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
COUR income_statement (quarterly, 2025-06-30) — Pretax Income: -7000000.00
COUR cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 5400000.00
COUR balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
COUR cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -400000.00
COUR balance_sheet (quarterly, 2025-06-30) — Receivables: 67200000.00
COUR income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 84400000.00
COUR income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7400000.00
COUR cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
COUR income_statement (quarterly, 2025-06-30) — Research And Development: 29300000.00
COUR income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 0.00
COUR balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -875800000.00
COUR cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
COUR income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 63600000.00
COUR income_statement (quarterly, 2025-06-30) — Selling General And Administration: 88500000.00
COUR balance_sheet (quarterly, 2025-06-30) — Share Issued: 165300000.00
COUR income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
COUR cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 23800000.00
COUR balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 627000000.00
COUR balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 600600000.00
COUR income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
COUR income_statement (quarterly, 2025-06-30) — Tax Provision: 800000.00
COUR income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
COUR balance_sheet (quarterly, 2025-06-30) — Total Assets: 979900000.00
COUR balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 627000000.00
COUR balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 627000000.00
COUR income_statement (quarterly, 2025-06-30) — Total Expenses: 202200000.00
COUR balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 352900000.00
COUR balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 98000000.00
COUR balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 6700000.00
COUR income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -15100000.00
COUR income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
COUR income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
COUR balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 1800000.00
COUR balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 17000000.00
COUR balance_sheet (quarterly, 2025-06-30) — Working Capital: 535700000.00
COUR income_statement (quarterly, 2025-09-30) — +Operating Expense: 121600000.00
COUR income_statement (quarterly, 2025-09-30) — +Total Revenue: 194200000.00
COUR balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 46800000.00
COUR balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -78100000.00
COUR balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 1523900000.00
COUR cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 600000.00
COUR income_statement (quarterly, 2025-09-30) — Basic Average Shares: 164600000.00
COUR income_statement (quarterly, 2025-09-30) — Basic EPS: -0.05
COUR cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 775800000.00
COUR cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -5200000.00
COUR cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -5000000.00
COUR balance_sheet (quarterly, 2025-09-30) — Capital Stock: 0.00
COUR balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 797700000.00
COUR balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 797700000.00
COUR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -3900000.00
COUR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -7300000.00
COUR cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 33900000.00
COUR cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 5600000.00
COUR cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 6300000.00
COUR cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -8700000.00
COUR cash_flow (quarterly, 2025-09-30) — Change In Payable: 5600000.00
COUR cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 11900000.00
COUR cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 0.00
COUR cash_flow (quarterly, 2025-09-30) — Change In Receivables: 8400000.00
COUR cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 11600000.00
COUR cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 8400000.00
COUR cash_flow (quarterly, 2025-09-30) — Changes In Cash: 22700000.00
COUR balance_sheet (quarterly, 2025-09-30) — Common Stock: 0.00
COUR balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 639500000.00
COUR cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 0.00
COUR income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 88200000.00
COUR balance_sheet (quarterly, 2025-09-30) — Current Assets: 897300000.00
COUR balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 20300000.00
COUR balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 177400000.00
COUR balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 177400000.00
COUR balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 349500000.00
COUR cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 7300000.00
COUR cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 7300000.00
COUR income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 164600000.00
COUR income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.05
COUR income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -8600000.00
COUR income_statement (quarterly, 2025-09-30) — EBIT: -15600000.00
COUR income_statement (quarterly, 2025-09-30) — EBITDA: -8300000.00
COUR cash_flow (quarterly, 2025-09-30) — End Cash Position: 798500000.00
COUR cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -3900000.00
COUR cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 28700000.00
COUR income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 24200000.00
COUR balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 25600000.00
COUR balance_sheet (quarterly, 2025-09-30) — Gross PPE: 119900000.00
COUR income_statement (quarterly, 2025-09-30) — Gross Profit: 106000000.00
COUR cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 1800000.00
COUR income_statement (quarterly, 2025-09-30) — Interest Income: 8300000.00
COUR income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 8300000.00
COUR balance_sheet (quarterly, 2025-09-30) — Invested Capital: 639500000.00
COUR cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -7300000.00
COUR balance_sheet (quarterly, 2025-09-30) — Leases: 1100000.00
COUR balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 118800000.00
COUR cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
COUR income_statement (quarterly, 2025-09-30) — Net Income: -8600000.00
COUR income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -8600000.00
COUR income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -8600000.00
COUR income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -8600000.00
COUR income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -8600000.00
COUR cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -8600000.00
COUR income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -8600000.00
COUR income_statement (quarterly, 2025-09-30) — Net Interest Income: 8300000.00
COUR cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 0.00
COUR income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 8300000.00
COUR cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -8700000.00
COUR cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -2100000.00
COUR balance_sheet (quarterly, 2025-09-30) — Net PPE: 41800000.00
COUR cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -200000.00
COUR balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 613900000.00
COUR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 1600000.00
COUR balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 1600000.00
COUR income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -8300000.00
COUR income_statement (quarterly, 2025-09-30) — Normalized Income: -8600000.00
COUR cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 33900000.00
COUR income_statement (quarterly, 2025-09-30) — Operating Income: -15600000.00
COUR income_statement (quarterly, 2025-09-30) — Operating Revenue: 194200000.00
COUR balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 166200000.00
COUR balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 20600000.00
COUR balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 113800000.00
COUR income_statement (quarterly, 2025-09-30) — Other Gand A: 24200000.00
COUR income_statement (quarterly, 2025-09-30) — Other Income Expense: -500000.00
COUR balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 25600000.00
COUR cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 0.00
COUR balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 30600000.00
COUR balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 4700000.00
COUR income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -500000.00
COUR balance_sheet (quarterly, 2025-09-30) — Other Payable: 26300000.00
COUR balance_sheet (quarterly, 2025-09-30) — Other Receivables: 11900000.00
COUR balance_sheet (quarterly, 2025-09-30) — Payables: 26300000.00
COUR balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 26300000.00
COUR balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 32000000.00
COUR balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
COUR income_statement (quarterly, 2025-09-30) — Pretax Income: -7800000.00
COUR cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 4800000.00
COUR balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
COUR cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -200000.00
COUR balance_sheet (quarterly, 2025-09-30) — Receivables: 58700000.00
COUR income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 88200000.00
COUR income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7300000.00
COUR cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 0.00
COUR income_statement (quarterly, 2025-09-30) — Research And Development: 30000000.00
COUR income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 0.00
COUR balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -884400000.00
COUR cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
COUR income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 67400000.00
COUR income_statement (quarterly, 2025-09-30) — Selling General And Administration: 91600000.00
COUR balance_sheet (quarterly, 2025-09-30) — Share Issued: 166200000.00
COUR income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
COUR cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 23000000.00
COUR balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 639500000.00
COUR balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 613900000.00
COUR income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
COUR income_statement (quarterly, 2025-09-30) — Tax Provision: 800000.00
COUR income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
COUR balance_sheet (quarterly, 2025-09-30) — Total Assets: 995300000.00
COUR balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 639500000.00
COUR balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 639500000.00
COUR income_statement (quarterly, 2025-09-30) — Total Expenses: 209800000.00
COUR balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 355800000.00
COUR balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 98000000.00
COUR balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 6300000.00
COUR income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -15600000.00
COUR income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
COUR income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
COUR balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 0.00
COUR balance_sheet (quarterly, 2025-09-30) — Working Capital: 547800000.00
COUR income_statement (annual, 2025-12-31) — +Operating Expense: 491700000.00
COUR income_statement (quarterly, 2025-12-31) — +Operating Expense: 139100000.00
COUR income_statement (annual, 2025-12-31) — +Total Revenue: 757500000.00
COUR income_statement (quarterly, 2025-12-31) — +Total Revenue: 196900000.00
COUR balance_sheet (annual, 2025-12-31) — Accounts Receivable: 58000000.00
COUR balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 58000000.00
COUR balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -74900000.00
COUR balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -74900000.00
COUR balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 1546900000.00
COUR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 1546900000.00
COUR cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 3700000.00
COUR cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 600000.00
COUR income_statement (annual, 2025-12-31) — Basic Average Shares: 163800000.00
COUR income_statement (quarterly, 2025-12-31) — Basic Average Shares: 167200000.00
COUR income_statement (annual, 2025-12-31) — Basic EPS: -0.31
COUR income_statement (quarterly, 2025-12-31) — Basic EPS: -0.16
COUR cash_flow (annual, 2025-12-31) — Beginning Cash Position: 728400000.00
COUR cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 798500000.00
COUR cash_flow (annual, 2025-12-31) — Capital Expenditure: -19600000.00
COUR cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -5200000.00
COUR cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -18100000.00
COUR cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -4800000.00
COUR balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
COUR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 0.00
COUR balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 792600000.00
COUR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 792600000.00
COUR balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 792600000.00
COUR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 792600000.00
COUR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -13500000.00
COUR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3100000.00
COUR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -30200000.00
COUR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7800000.00
COUR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 108700000.00
COUR cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 5800000.00
COUR cash_flow (annual, 2025-12-31) — Change In Account Payable: 8000000.00
COUR cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -1100000.00
COUR cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 1700000.00
COUR cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 4300000.00
COUR cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 21000000.00
COUR cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 3200000.00
COUR cash_flow (annual, 2025-12-31) — Change In Payable: 8000000.00
COUR cash_flow (quarterly, 2025-12-31) — Change In Payable: -1100000.00
COUR cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 9700000.00
COUR cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 3200000.00
COUR cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 7400000.00
COUR cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 1200000.00
COUR cash_flow (annual, 2025-12-31) — Change In Receivables: -5700000.00
COUR cash_flow (quarterly, 2025-12-31) — Change In Receivables: -6700000.00
COUR cash_flow (annual, 2025-12-31) — Change In Working Capital: 32400000.00
COUR cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 900000.00
COUR cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -5700000.00
COUR cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -6700000.00
COUR cash_flow (annual, 2025-12-31) — Changes In Cash: 65000000.00
COUR cash_flow (quarterly, 2025-12-31) — Changes In Cash: -5100000.00
COUR balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
COUR balance_sheet (quarterly, 2025-12-31) — Common Stock: 0.00
COUR balance_sheet (annual, 2025-12-31) — Common Stock Equity: 635700000.00
COUR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 635700000.00
COUR cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
COUR cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
COUR income_statement (annual, 2025-12-31) — Cost Of Revenue: 344100000.00
COUR income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 90100000.00
COUR balance_sheet (annual, 2025-12-31) — Current Assets: 898100000.00
COUR balance_sheet (quarterly, 2025-12-31) — Current Assets: 898100000.00
COUR balance_sheet (annual, 2025-12-31) — Current Deferred Assets: 19600000.00
COUR balance_sheet (quarterly, 2025-12-31) — Current Deferred Assets: 19600000.00
COUR balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 180900000.00
COUR balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 180900000.00
COUR balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 180900000.00
COUR balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 180900000.00
COUR balance_sheet (annual, 2025-12-31) — Current Liabilities: 357900000.00
COUR balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 357900000.00
COUR cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 28800000.00
COUR cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 7000000.00
COUR cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 28800000.00
COUR cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 7000000.00
COUR income_statement (annual, 2025-12-31) — Diluted Average Shares: 163800000.00
COUR income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 167200000.00
COUR income_statement (annual, 2025-12-31) — Diluted EPS: -0.31
COUR income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.16
COUR income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -51000000.00
COUR income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -26800000.00
COUR income_statement (annual, 2025-12-31) — EBIT: -78300000.00
COUR income_statement (quarterly, 2025-12-31) — EBIT: -32300000.00
COUR income_statement (annual, 2025-12-31) — EBITDA: -49500000.00
COUR income_statement (quarterly, 2025-12-31) — EBITDA: -25300000.00
COUR cash_flow (annual, 2025-12-31) — End Cash Position: 793400000.00
COUR cash_flow (quarterly, 2025-12-31) — End Cash Position: 793400000.00
COUR cash_flow (annual, 2025-12-31) — Financing Cash Flow: -13500000.00
COUR cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -3100000.00
COUR cash_flow (annual, 2025-12-31) — Free Cash Flow: 89100000.00
COUR cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 600000.00
COUR income_statement (annual, 2025-12-31) — General And Administrative Expense: 114400000.00
COUR income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 38400000.00
COUR balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 27100000.00
COUR balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 27100000.00
COUR balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 58000000.00
COUR balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 58000000.00
COUR balance_sheet (annual, 2025-12-31) — Gross PPE: 118300000.00
COUR balance_sheet (quarterly, 2025-12-31) — Gross PPE: 118300000.00
COUR income_statement (annual, 2025-12-31) — Gross Profit: 413400000.00
COUR income_statement (quarterly, 2025-12-31) — Gross Profit: 106800000.00
COUR cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 6000000.00
COUR cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 2300000.00
COUR income_statement (annual, 2025-12-31) — Interest Income: 32000000.00
COUR income_statement (quarterly, 2025-12-31) — Interest Income: 7900000.00
COUR income_statement (annual, 2025-12-31) — Interest Income Non Operating: 32000000.00
COUR income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 7900000.00
COUR balance_sheet (annual, 2025-12-31) — Invested Capital: 635700000.00
COUR balance_sheet (quarterly, 2025-12-31) — Invested Capital: 635700000.00
COUR cash_flow (annual, 2025-12-31) — Investing Cash Flow: -30200000.00
COUR cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -7800000.00
COUR balance_sheet (annual, 2025-12-31) — Leases: 1100000.00
COUR balance_sheet (quarterly, 2025-12-31) — Leases: 1100000.00
COUR balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 117200000.00
COUR balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 117200000.00
COUR cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
COUR cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
COUR cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
COUR income_statement (annual, 2025-12-31) — Net Income: -51000000.00
COUR income_statement (quarterly, 2025-12-31) — Net Income: -26800000.00
COUR income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -51000000.00
COUR income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -26800000.00
COUR income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -51000000.00
COUR income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -26800000.00
COUR income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -51000000.00
COUR income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -26800000.00
COUR income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -51000000.00
COUR income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -26800000.00
COUR cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -51000000.00
COUR cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -26800000.00
COUR income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -51000000.00
COUR income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -26800000.00
COUR income_statement (annual, 2025-12-31) — Net Interest Income: 32000000.00
COUR income_statement (quarterly, 2025-12-31) — Net Interest Income: 7900000.00
COUR cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
COUR cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
COUR income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 32000000.00
COUR income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 7900000.00
COUR cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -27600000.00
COUR cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -5800000.00
COUR cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -10600000.00
COUR cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -2600000.00
COUR balance_sheet (annual, 2025-12-31) — Net PPE: 43400000.00
COUR balance_sheet (quarterly, 2025-12-31) — Net PPE: 43400000.00
COUR cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -1500000.00
COUR cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -400000.00
COUR balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 608600000.00
COUR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 608600000.00
COUR balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 1400000.00
COUR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 1400000.00
COUR balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 1400000.00
COUR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 1400000.00
COUR income_statement (annual, 2025-12-31) — Normalized EBITDA: -50400000.00
COUR income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -25300000.00
COUR income_statement (annual, 2025-12-31) — Normalized Income: -51711000.00
COUR income_statement (quarterly, 2025-12-31) — Normalized Income: -26800000.00
COUR cash_flow (annual, 2025-12-31) — Operating Cash Flow: 108700000.00
COUR cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 5800000.00
COUR income_statement (annual, 2025-12-31) — Operating Income: -78300000.00
COUR income_statement (quarterly, 2025-12-31) — Operating Income: -32300000.00
COUR income_statement (annual, 2025-12-31) — Operating Revenue: 757500000.00
COUR income_statement (quarterly, 2025-12-31) — Operating Revenue: 196900000.00
COUR balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 167908653.00
COUR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 167908653.00
COUR balance_sheet (annual, 2025-12-31) — Other Current Assets: 20500000.00
COUR balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 20500000.00
COUR balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 110500000.00
COUR balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 110500000.00
COUR income_statement (annual, 2025-12-31) — Other Gand A: 114400000.00
COUR income_statement (quarterly, 2025-12-31) — Other Gand A: 38400000.00
COUR income_statement (annual, 2025-12-31) — Other Income Expense: 400000.00
COUR income_statement (quarterly, 2025-12-31) — Other Income Expense: -400000.00
COUR balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 27100000.00
COUR balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 27100000.00
COUR cash_flow (annual, 2025-12-31) — Other Non Cash Items: -300000.00
COUR cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 0.00
COUR balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 31400000.00
COUR balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 31400000.00
COUR balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 5000000.00
COUR balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 5000000.00
COUR income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -500000.00
COUR income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -400000.00
COUR balance_sheet (annual, 2025-12-31) — Other Payable: 29800000.00
COUR balance_sheet (quarterly, 2025-12-31) — Other Payable: 29800000.00
COUR balance_sheet (annual, 2025-12-31) — Other Receivables: 7400000.00
COUR balance_sheet (quarterly, 2025-12-31) — Other Receivables: 7400000.00
COUR balance_sheet (annual, 2025-12-31) — Payables: 29800000.00
COUR balance_sheet (quarterly, 2025-12-31) — Payables: 29800000.00
COUR balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 29800000.00
COUR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 29800000.00
COUR balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 36700000.00
COUR balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 36700000.00
COUR balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
COUR balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
COUR income_statement (annual, 2025-12-31) — Pretax Income: -45900000.00
COUR income_statement (quarterly, 2025-12-31) — Pretax Income: -24800000.00
COUR cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 14100000.00
COUR cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 2700000.00
COUR balance_sheet (annual, 2025-12-31) — Properties: 0.00
COUR balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
COUR cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
COUR cash_flow (annual, 2025-12-31) — Purchase Of Investment: 0.00
COUR cash_flow (annual, 2025-12-31) — Purchase Of PPE: -1500000.00
COUR cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -400000.00
COUR balance_sheet (annual, 2025-12-31) — Receivables: 65400000.00
COUR balance_sheet (quarterly, 2025-12-31) — Receivables: 65400000.00
COUR income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 344100000.00
COUR income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 90100000.00
COUR income_statement (annual, 2025-12-31) — Reconciled Depreciation: 28800000.00
COUR income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7000000.00
COUR cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
COUR cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
COUR income_statement (annual, 2025-12-31) — Research And Development: 121600000.00
COUR income_statement (quarterly, 2025-12-31) — Research And Development: 32800000.00
COUR income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: -900000.00
COUR income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
COUR balance_sheet (annual, 2025-12-31) — Retained Earnings: -911200000.00
COUR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -911200000.00
COUR cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
COUR cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
COUR income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 255700000.00
COUR income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 67900000.00
COUR income_statement (annual, 2025-12-31) — Selling General And Administration: 370100000.00
COUR income_statement (quarterly, 2025-12-31) — Selling General And Administration: 106300000.00
COUR balance_sheet (annual, 2025-12-31) — Share Issued: 167908653.00
COUR balance_sheet (quarterly, 2025-12-31) — Share Issued: 167908653.00
COUR income_statement (annual, 2025-12-31) — Special Income Charges: 900000.00
COUR income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
COUR cash_flow (annual, 2025-12-31) — Stock Based Compensation: 95100000.00
COUR cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 24100000.00
COUR balance_sheet (annual, 2025-12-31) — Stockholders Equity: 635700000.00
COUR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 635700000.00
COUR balance_sheet (annual, 2025-12-31) — Tangible Book Value: 608600000.00
COUR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 608600000.00
COUR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 189000.00
COUR income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
COUR income_statement (annual, 2025-12-31) — Tax Provision: 5100000.00
COUR income_statement (quarterly, 2025-12-31) — Tax Provision: 2000000.00
COUR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
COUR income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
COUR balance_sheet (annual, 2025-12-31) — Total Assets: 1000000000.00
COUR balance_sheet (quarterly, 2025-12-31) — Total Assets: 1000000000.00
COUR balance_sheet (annual, 2025-12-31) — Total Capitalization: 635700000.00
COUR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 635700000.00
COUR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 635700000.00
COUR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 635700000.00
COUR income_statement (annual, 2025-12-31) — Total Expenses: 835800000.00
COUR income_statement (quarterly, 2025-12-31) — Total Expenses: 229200000.00
COUR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 364300000.00
COUR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 364300000.00
COUR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 101900000.00
COUR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 101900000.00
COUR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6400000.00
COUR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 6400000.00
COUR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -77400000.00
COUR income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -32300000.00
COUR income_statement (annual, 2025-12-31) — Total Unusual Items: 900000.00
COUR income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
COUR income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 900000.00
COUR income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
COUR balance_sheet (annual, 2025-12-31) — Treasury Stock: 0.00
COUR balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 0.00
COUR balance_sheet (annual, 2025-12-31) — Working Capital: 540200000.00
COUR balance_sheet (quarterly, 2025-12-31) — Working Capital: 540200000.00
COUR income_statement (quarterly, 2026-03-31) — +Operating Expense: 133900000.00
COUR income_statement (quarterly, 2026-03-31) — +Total Revenue: 195700000.00
COUR balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 45700000.00
COUR balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -80500000.00
COUR balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 1563500000.00
COUR income_statement (quarterly, 2026-03-31) — Basic Average Shares: 168700000.00
COUR income_statement (quarterly, 2026-03-31) — Basic EPS: -0.12
COUR cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 793400000.00
COUR cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5800000.00
COUR cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -5600000.00
COUR balance_sheet (quarterly, 2026-03-31) — Capital Stock: 0.00
COUR balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 789800000.00
COUR balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 789800000.00
COUR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -5700000.00
COUR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -11600000.00
COUR cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 14600000.00
COUR cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -700000.00
COUR cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -14200000.00
COUR cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 19300000.00
COUR cash_flow (quarterly, 2026-03-31) — Change In Payable: -700000.00
COUR cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -14900000.00
COUR cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -3000000.00
COUR cash_flow (quarterly, 2026-03-31) — Change In Receivables: 5400000.00
COUR cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 6800000.00
COUR cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 5400000.00
COUR cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2700000.00
COUR balance_sheet (quarterly, 2026-03-31) — Common Stock: 0.00
COUR balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 631800000.00
COUR income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 87100000.00
COUR balance_sheet (quarterly, 2026-03-31) — Current Assets: 893400000.00
COUR balance_sheet (quarterly, 2026-03-31) — Current Deferred Assets: 19000000.00
COUR balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 200100000.00
COUR balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 200100000.00
COUR balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 362400000.00
COUR cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 7500000.00
COUR cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 7500000.00
COUR income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 168700000.00
COUR income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.12
COUR income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -20500000.00
COUR income_statement (quarterly, 2026-03-31) — EBIT: -25300000.00
COUR income_statement (quarterly, 2026-03-31) — EBITDA: -17800000.00
COUR cash_flow (quarterly, 2026-03-31) — End Cash Position: 790700000.00
COUR cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -5700000.00